Two bills dealing with drug prescriptions were combined into a single measure and advanced Thursday by House and Senate negotiators.
The conference committee agreed to fold these bills into Senate Bill 134:
• SB 325 — would allow for the distribution to practitioners of free samples of Schedule V non-narcotic depressants. It also would add Carisoprodol, a muscle relaxant, to the Schedule IV controlled substances list and Ezogabine, an anticonvulsant, to the Schedule V list.
• SB 327 — among other things would lay out who could access data from the Prescription Monitoring Program and modify regulations to allow electronic prescriptions for controlled substances.
The original contents of SB 134 became law last year as part of House Bill 2182.
The House and Senate could vote on the conference committee’s recommendation as soon as Friday.
The committee did not discuss plans to meet again.